Trade CRBU anytime, even after market hours
Regulated by
MAS
Trusted by
400,000+ users
Caribou Biosciences, Inc. (CRBU) is trading at US$1.62, down 2.71% today as of Aug 28, 12:43 EDT. The company has a market capitalisation of US$177.96M. Over the past 52 weeks, CRBU has traded between US$1.38 and US$3.54. On Syfe you can trade CRBU with $0 commission and add it to your watchlist.
| Previous close | US$1.66 |
|---|---|
| Market cap | US$177.96M |
| 52-week range | US$1.38 – US$3.54 |
| Volume | 900.65K |
| Exchange | US |
Add to Watchlist
Set Price Alert
Caribou Biosciences, Inc.
Caribou Biosciences, Inc. engages in the development of an internal pipeline of off-the-shelf CAR-T and CAR-NK cell therapies. Its tools and technologies provide transformative capabilities to basic and applied biological research, therapeutic development, agricultural biotechnology, and industrial biotechnology. The company was founded by Jennifer A. Doudna, Rachel E. Haurwitz, Martin Jinek and James Berger on October 28, 2011 and is headquartered in Berkeley, CA.
Year: 2021
Caribou Biosciences Potential Non-Hodgkin Lymphoma Cell Therapy Shows 'Durable' Responses
Jun 11, 12:40 PM · MT Newswires
Caribou Biosciences Receives US FDA Advanced Therapy Status For Multiple Myeloma Drug
Mar 31, 1:08 PM · MT Newswires
Caribou Biosciences, Inc. (CRBU) stock is trading at US$1.62, -2.71% from the previous close of US$1.66.
The market cap for Caribou Biosciences, Inc. (CRBU) stock is approximately US$177.96M.
The 52-week high for Caribou Biosciences, Inc. (CRBU) stock is US$3.54.
The 52-week low for Caribou Biosciences, Inc. (CRBU) stock is US$1.38.
Caribou Biosciences, Inc. (CRBU) does not currently pay a dividend.
Stay on top of CRBU
Price moves, news and earnings — straight to your inbox.
Est. order value
US$0.00
Snapshot
